Prestige Wealth Management Group LLC Biomarin Pharmaceutical Inc Transaction History

Prestige Wealth Management Group LLC

$491 Million
Q3 2025

A detailed history of Prestige Wealth Management Group LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 48 shares of BMRN stock, worth $2,627. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 34 41.18%

Holding current value

$2,627

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$52.62 - $61.93 $736 - $867	14 Added 41.18%	48 $2,000
Q2 2025 Aug 13, 2025	SELL	$54.08 - $68.32 $2,271 - $2,869	-42 Reduced 55.26%	34 $1,000
Q1 2025 May 12, 2025	BUY	$61.25 - $72.83 $2,572 - $3,058	42 Added 123.53%	76 $5,000
Q4 2024 Feb 11, 2025	SELL	$61.93 - $70.49 $1,548 - $1,762	-25 Reduced 42.37%	34 $2,000
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $1,725 - $2,346	25 Added 73.53%	59 $4,000

Q2 2024 Aug 06, 2024	SELL	$74.43 - $92.22 $1,339 - $1,659	-18 Reduced 34.62%	34 $2,000
Q1 2024 Apr 26, 2024	SELL	$83.81 - $99.0 $5,363 - $6,336	-64 Reduced 55.17%	52 $4,000
Q4 2023 Apr 26, 2024	BUY	$76.22 - $98.51 $457 - $591	6 Added 5.45%	116 $11,000
Q4 2023 Feb 08, 2024	BUY	$76.22 - $98.51 $457 - $591	6 Added 5.45%	116 $11,000
Q3 2023 Apr 26, 2024	SELL	$85.07 - $94.48 $2,296 - $2,550	-27 Reduced 19.71%	110 $9,000
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $2,296 - $2,550	-27 Reduced 19.71%	110 $9,000
Q1 2023 Apr 26, 2024	BUY	$87.74 - $117.27 $7,457 - $9,967	85 Added 163.46%	137 $13,000
Q1 2023 May 16, 2023	BUY	$87.74 - $117.27 $614 - $820	7 Added 5.38%	137 $13,000
Q4 2022 Feb 07, 2023	BUY	$80.93 - $108.63 $728 - $977	9 Added 7.44%	130 $13,000
Q3 2022 Nov 01, 2022	SELL	$82.16 - $96.94 $8,216 - $9,694	-100 Reduced 45.25%	121 $11,000
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $5,146 - $6,253	72 Added 48.32%	221 $19,000
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $897 - $1,025	12 Added 8.76%	149 $11,000
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $1,208 - $1,356	16 Added 13.22%	137 $11,000
Q1 2021 May 13, 2021	SELL	$74.73 - $90.69 $1,419 - $1,723	-19 Reduced 13.57%	121 $9,000
Q4 2020 Feb 17, 2021	BUY	$72.61 - $90.2 $5,300 - $6,584	73 Added 108.96%	140 $12,000
Q3 2020 Oct 26, 2020	SELL	$71.87 - $131.03 $4,312 - $7,861	-60 Reduced 47.24%	67 $5,000
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $5,091 - $7,950	64 Added 101.59%	127 $16,000
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $4,496 - $6,101	63 New	63 $5,000
Q1 2019 Aug 16, 2019	SELL	$84.2 - $98.62 $10,693 - $12,524	-127 Closed	0 $0
Q4 2018 Apr 16, 2019	BUY	$80.14 - $106.07 $10,177 - $13,470	127 New	127 $11,000

Others Institutions Holding BMRN

# of Institutions

667

Shares Held

182M

Call Options Held

1.48M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Biomarin Pharmaceutical Inc Transaction History